Supplemental material
Acta Oncologica
Volume 60, 2021 - Issue 12
Open access
2,419
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: CLINICAL ONCOLOGY
A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma
Milan van Meekerena Department of Medical Oncology, Leiden University Medical Center, Leiden, the NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-6934-8652View further author information
, https://orcid.org/0000-0001-6934-8652View further author information
Judith V. M. G. Boveeb Department of Pathology, Leiden University Medical Center, Leiden, The Netherlandshttps://orcid.org/0000-0003-1155-0481View further author information
, Frits van Coevordenc Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the NetherlandsView further author information
, Winan van Houdtc Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the NetherlandsView further author information
, Yvonne Schragec Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the NetherlandsView further author information
, Anne Miek Koenend Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the NetherlandsView further author information
, Aisha B. Miahe Department of Clinical Oncology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United KingdomView further author information
, Shane Zaidie Department of Clinical Oncology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United KingdomView further author information
, Andrew J. Hayesf Department of Surgery, The Royal Marsden Hospital and The Institute of Cancer Research, London, United KingdomView further author information
, Khin Thwayg Department of Pathology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United KingdomView further author information
, Stijn Krolh Department of Radiotherapy, Leiden University Medical Center, Leiden, the NetherlandsView further author information
, Marta Fioccoi Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the NetherlandsView further author information
, Hans Gelderbloma Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlandshttps://orcid.org/0000-0001-9270-8636View further author information
, Neeltje Steeghsd Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the NetherlandsView further author information
& Rick L. Haash Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands;j Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlandshttps://orcid.org/0000-0003-4834-4331View further author information
show all
Pages 1557-1564
|
Received 02 Jul 2021, Accepted 13 Aug 2021, Published online: 23 Sep 2021
Related Research Data
A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.